NovaBay Pharmaceuticals Net Profit Margin 2007-2020 | NBY

NovaBay Pharmaceuticals net profit margin from 2007 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
NovaBay Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.01B $-0.01B -100.00%
2020-03-31 $0.01B $-0.01B -112.50%
2019-12-31 $0.01B $-0.01B -157.14%
2019-09-30 $0.01B $-0.01B -88.89%
2019-06-30 $0.01B $-0.01B -100.00%
2019-03-31 $0.01B $-0.01B -81.82%
2018-12-31 $0.01B $-0.01B -53.85%
2018-09-30 $0.02B $-0.01B -33.33%
2018-06-30 $0.02B $-0.01B -31.25%
2018-03-31 $0.02B $-0.01B -29.41%
2017-12-31 $0.02B $-0.01B -38.89%
2017-09-30 $0.02B $-0.01B -62.50%
2017-06-30 $0.02B $-0.01B -80.00%
2017-03-31 $0.01B $-0.01B -92.86%
2016-12-31 $0.01B $-0.01B -116.67%
2016-09-30 $0.01B $-0.02B -160.00%
2016-06-30 $0.01B $-0.02B -212.50%
2016-03-31 $0.01B $-0.02B -316.67%
2015-12-31 $0.01B $-0.02B -380.00%
2015-09-30 $0.00B $-0.02B -633.33%
2015-06-30 $0.00B $-0.02B -900.00%
2015-03-31 $0.00B $-0.02B -1600.00%
2014-12-31 $0.00B $-0.02B inf%
2014-09-30 $0.00B $-0.02B -1500.00%
2014-06-30 $0.00B $-0.02B -750.00%
2014-03-31 $0.00B $-0.02B -533.33%
2013-12-31 $0.00B $-0.02B -400.00%
2013-09-30 $0.00B $-0.01B -350.00%
2013-06-30 $0.01B $-0.01B -142.86%
2013-03-31 $0.01B $-0.01B -114.29%
2012-12-31 $0.01B $-0.01B -100.00%
2012-09-30 $0.01B $-0.01B -128.57%
2012-06-30 $0.01B $-0.01B -150.00%
2012-03-31 $0.01B $-0.01B -70.00%
2011-12-31 $0.01B $-0.01B -54.55%
2011-09-30 $0.01B $-0.00B -15.38%
2011-06-30 $0.01B $-0.00B -33.33%
2011-03-31 $0.01B $-0.01B -50.00%
2010-12-31 $0.01B $-0.01B -50.00%
2010-09-30 $0.01B $-0.00B -14.29%
2010-06-30 $0.02B 0 0.00%
2010-03-31 $0.01B $0.00B 7.14%
2009-12-31 $0.02B $0.00B 20.00%
2009-09-30 $0.01B $-0.00B -20.00%
2009-06-30 $0.01B $-0.00B -33.33%
2009-03-31 $0.01B $-0.01B -62.50%
2008-12-31 $0.01B $-0.01B -133.33%
2008-09-30 $0.01B $-0.01B -116.67%
2008-06-30 $0.01B $-0.01B -160.00%
2008-03-31 $0.01B $-0.01B -160.00%
2007-12-31 $0.01B $-0.01B -120.00%
2007-09-30 $0.00B $-0.01B -200.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.027B $0.007B
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.401B 42.89
Takeda Pharmaceutical (TAK) Japan $50.759B 8.85
Astellas Pharma (ALPMY) Japan $25.376B 0.00
Eisai (ESALY) Japan $23.672B 20.00
Merck (MKGAF) Germany $20.265B 26.58
UCB SA (UCBJF) Belgium $20.005B 0.00
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $14.630B 47.56
Grifols, S.A (GRFS) Spain $11.915B 14.56
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 25.17
Neurocrine Biosciences (NBIX) United States $9.189B 35.57
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.076B 13.36
IPSEN SA ADR (IPSEY) France $7.818B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.401B 40.55
Orion OYJ (ORINY) Finland $6.272B 21.76
Arrowhead Pharmaceuticals (ARWR) United States $6.078B 0.00
United Therapeutics (UTHR) United States $5.864B 12.49
Evotec AG (EVTCY) Germany $4.416B 142.16
Sage Therapeutics (SAGE) United States $3.734B 0.00
ChemoCentryx (CCXI) United States $3.599B 0.00
PTC Therapeutics (PTCT) United States $3.552B 0.00
FibroGen (FGEN) United States $3.466B 0.00
Hypermarcas (HYPMY) Brazil $3.163B 11.64
Nektar Therapeutics (NKTR) United States $2.846B 0.00
Pacira BioSciences (PCRX) United States $2.226B 58.51
Taro Pharmaceutical Industries (TARO) Israel $2.211B 11.28
Xencor (XNCR) United States $2.196B 0.00
Revolution Medicines (RVMD) United States $2.089B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.003B 0.00
Corcept Therapeutics (CORT) United States $1.980B 18.22
Cronos Group (CRON) Canada $1.914B 0.00
USANA Health Sciences (USNA) United States $1.693B 14.92
Ironwood Pharmaceuticals (IRWD) United States $1.520B 10.56
Heron Therapeutics (HRTX) United States $1.384B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.321B 12.60
Theravance Biopharma (TBPH) Cayman Islands $1.215B 0.00
Trillium Therapeutics (TRIL) Canada $1.188B 0.00
Endo (ENDP) Ireland $1.163B 1.72
Karyopharm Therapeutics (KPTI) United States $1.137B 0.00
Zogenix (ZGNX) United States $1.132B 0.00
Indivior (INVVY) United States $1.070B 13.27
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
Translate Bio (TBIO) United States $0.961B 0.00
ImmunoGen (IMGN) United States $0.944B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.883B 550.13
Esperion Therapeutics (ESPR) United States $0.848B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Tilray (TLRY) Canada $0.719B 0.00
Ocular Therapeutix (OCUL) United States $0.663B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.647B 32.29
BioCryst Pharmaceuticals (BCRX) United States $0.641B 0.00
Radius Health (RDUS) United States $0.626B 0.00
Collegium Pharmaceutical (COLL) United States $0.621B 0.00
Flexion Therapeutics (FLXN) United States $0.588B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.562B 0.00
VAXART, INC (VXRT) United States $0.547B 0.00
Siga Technologies (SIGA) United States $0.501B 53.42
Spectrum Pharmaceuticals (SPPI) United States $0.493B 0.00
Aerie Pharmaceuticals (AERI) United States $0.479B 0.00
Molecular Templates (MTEM) United States $0.468B 0.00
Ardelyx (ARDX) United States $0.451B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.414B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.406B 0.00
Organogenesis Holdings (ORGO) United States $0.383B 0.00
Harpoon Therapeutics (HARP) United States $0.371B 0.00
Altimmune (ALT) United States $0.369B 0.00
TherapeuticsMD (TXMD) United States $0.359B 0.00
DURECT (DRRX) United States $0.357B 0.00
Profound Medical (PROF) Canada $0.336B 0.00
Akebia Therapeutics (AKBA) United States $0.335B 0.00
Concert Pharmaceuticals (CNCE) United States $0.327B 0.00
Redhill Biopharma (RDHL) Israel $0.318B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.313B 7.76
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
MEI Pharma (MEIP) United States $0.296B 0.00
Innate Pharma SA (IPHYF) France $0.291B 0.00
Jounce Therapeutics (JNCE) United States $0.290B 13.71
KalVista Pharmaceuticals (KALV) United States $0.287B 0.00
Menlo Therapeutics (VYNE) United States $0.273B 0.00
Rafael Holdings (RFL) United States $0.264B 0.00
Lannett Co Inc (LCI) United States $0.257B 5.97
Calithera Biosciences (CALA) United States $0.252B 0.00
CASI Pharmaceuticals (CASI) United States $0.252B 0.00
CTI BioPharma (CTIC) United States $0.234B 0.00
Xeris Pharmaceuticals (XERS) United States $0.226B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.223B 0.00
IMV INC (IMV) Canada $0.214B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.211B 0.00
Aduro Biotech (KDNY) United States $0.211B 0.00
Nature's Sunshine Products (NATR) United States $0.205B 20.17
Nivalis Therapeutics (ALPN) United States $0.184B 0.00
Otonomy (OTIC) United States $0.183B 0.00
Heat Biologics (HTBX) United States $0.177B 0.00
Aquestive Therapeutics (AQST) United States $0.173B 0.00
Taiwan Liposome (TLC) Taiwan $0.172B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.172B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.164B 0.00
Aclaris Therapeutics (ACRS) United States $0.163B 0.00
OptiNose (OPTN) United States $0.163B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.161B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.097B 0.00
MediWound (MDWD) Israel $0.093B 0.00
Lipocine (LPCN) United States $0.085B 0.00
Hemispherx BioPharma (AIM) United States $0.080B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.077B 0.00
ProPhase Labs (PRPH) United States $0.075B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.070B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.069B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.069B 0.00
ElectroCore (ECOR) United States $0.067B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.067B 0.00
Novan (NOVN) United States $0.066B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.065B 0.00
AgeX Therapeutics (AGE) United States $0.064B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.064B 0.00
Biomerica (BMRA) United States $0.063B 0.00
Infinity Pharmaceuticals (INFI) United States $0.062B 0.00
Addex Therapeutics (ADXN) Switzerland $0.060B 0.00
Nutriband (NTRB) United States $0.060B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.058B 0.00
Natural Alternatives (NAII) United States $0.051B 0.00
SCYNEXIS (SCYX) United States $0.047B 0.00
India Globalization Capital (IGC) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 26.82
Onconova Therapeutics (ONTX) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Recro Pharma (REPH) United States $0.042B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.034B 8.71
Bellicum Pharmaceuticals (BLCM) United States $0.032B 0.00
Neos Therapeutics (NEOS) United States $0.031B 0.00
GTx (ONCT) United States $0.030B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
Sundial Growers (SNDL) Canada $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Vical (BBI) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.017B 25.09
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
Bio-Path Holdings (BPTH) United States $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Iterum Therapeutics (ITRM) Ireland $0.010B 0.00
Shineco (TYHT) China $0.008B 0.00
JanOne (JAN) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00